Found 1 results

Smith DB, Kasamon YL, Kowalski J, Gocke C, Murphy K, Miller CB, Garrett-Mayer E, Tsai H-L, Qin L, Chia C et al..  2010.  K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(1):338-47. Abstract